Skip to main content
رجوع
Watch Compare

SRx Health Solutions, Inc.

جودة البيانات: 100%
SRXH
NYSE Manufacturing Food Products
KWD 0.14
▲ KWD 0.00 (2.31%)
القيمة السوقية: 49.23 M
السعر
KWD 0.14
القيمة السوقية
49.23 M
نطاق اليوم
KWD 0.13 — KWD 0.14
نطاق 52 أسبوعًا
KWD 0.08 — KWD 2.02
حجم التداول
25,302,690
فتح KWD 0.13
متوسط 50 يوم / 200 يوم
KWD 0.13
3.46% above
متوسط 50 يوم / 200 يوم
KWD 0.31
55.48% below

Quick Summary

النقاط الرئيسية

Revenue declined -38.61% annually over 5 years
Negative free cash flow of -11.44 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 42.71%

النمو

Revenue Growth (5Y)
-38.61%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)-81.32%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-646.80%
Op. Margin-173.30%

الأمان

Debt / Equity
N/A
Current Ratio0.80
Interest Coverage-7.70

التقييم

PE (TTM)
-0.93
أعلى من متوسط القطاع (-1.47)
P/B Ratio13.97
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -0.9 -1.5
P/B 14.0 1.6
ROE % — -53.5
Net Margin % -646.8 -41.5
Rev Growth 5Y % -38.6 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -81.32% Revenue Growth (3Y) -58.85%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -38.61% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 8.14 M Net Income (TTM) -52.66 M
ROE N/A ROA -172.54%
Gross Margin 2.42% Operating Margin -173.30%
Net Margin -646.80% Free Cash Flow (TTM) -11.44 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.80
Interest Coverage -7.70 Asset Turnover 0.27
Working Capital -4.69 M Tangible Book Value 3.52 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.93 Forward P/E N/A
P/B Ratio 13.97 P/S Ratio 6.05
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23.24%
Market Cap 49.23 M Enterprise Value 36.17 M
Per Share
EPS (Diluted TTM) -2.02 Revenue / Share 0.02
FCF / Share -0.03 OCF / Share -0.03
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 21.73%
SBC-Adj. FCF -16.94 M Growth Momentum -42.71

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 6.53 M 34.98 M 38.59 M 54.66 M 46.01 M
Net Income -45.01 M -168,000.0 -22.77 M -39.32 M 3.39 M
EPS (Diluted) -2.13 -0.10 -32.29 -1.34 0.14
Gross Profit 1.53 M 12.99 M 11.80 M 15.26 M 15.37 M
Operating Income -11.41 M -5.97 M -21.18 M -38.78 M -17.28 M
EBITDA — — — — —
R&D Expenses — 100,000.0 100,000.0 500,000.0 500,000.0
SG&A Expenses 12.93 M 18.96 M 24.44 M 32.46 M 28.51 M
D&A 31,000.0 130,000.0 1.68 M 1.69 M 1.66 M
Interest Expense 628,000.0 467,000.0 1.35 M -551,000.0 -3.22 M
Income Tax — 9,000.0 2,000.0 -18,000.0 37,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.40 M 15.80 M 16.74 M 38.68 M 74.66 M
Total Liabilities 8.00 M 7.15 M 13.76 M 17.15 M 16.79 M
Shareholders' Equity 407,000.0 8.65 M 2.98 M 21.53 M 57.88 M
Total Debt 35.99 M 2.58 M 5.45 M 11.61 M 10.27 M
Cash & Equivalents 1.31 M 3.07 M 4.46 M 3.17 M 21.73 M
Current Assets 8.13 M 15.00 M 16.23 M 27.53 M 43.92 M
Current Liabilities 3.54 M 7.15 M 13.69 M 5.58 M 7.34 M